A detailed history of Oppenheimer Asset Management Inc. transactions in Grifols Sa stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 58,677 shares of GRFS stock, worth $460,614. This represents 0.01% of its overall portfolio holdings.

Number of Shares
58,677
Previous 55,887 4.99%
Holding current value
$460,614
Previous $352,000 48.01%
% of portfolio
0.01%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$6.28 - $9.38 $17,521 - $26,170
2,790 Added 4.99%
58,677 $521,000
Q2 2024

Aug 08, 2024

BUY
$6.27 - $7.7 $126,152 - $154,924
20,120 Added 56.25%
55,887 $352,000
Q1 2024

May 06, 2024

SELL
$5.47 - $11.38 $2,373 - $4,938
-434 Reduced 1.2%
35,767 $238,000
Q4 2023

Feb 13, 2024

SELL
$7.71 - $11.56 $4,718 - $7,074
-612 Reduced 1.66%
36,201 $418,000
Q3 2023

Nov 07, 2023

SELL
$8.91 - $10.91 $16,839 - $20,619
-1,890 Reduced 4.88%
36,813 $336,000
Q2 2023

Aug 02, 2023

SELL
$7.14 - $9.29 $8,703 - $11,324
-1,219 Reduced 3.05%
38,703 $354,000
Q1 2023

May 10, 2023

BUY
$6.65 - $10.69 $73,655 - $118,402
11,076 Added 38.4%
39,922 $294,000
Q4 2022

Feb 06, 2023

SELL
$5.96 - $8.53 $89,620 - $128,265
-15,037 Reduced 34.27%
28,846 $245,000
Q3 2022

Nov 14, 2022

BUY
$5.95 - $14.3 $5,872 - $14,114
987 Added 2.3%
43,883 $270,000
Q2 2022

Aug 08, 2022

SELL
$10.6 - $13.28 $3,572 - $4,475
-337 Reduced 0.78%
42,896 $510,000
Q1 2022

May 12, 2022

BUY
$10.37 - $12.73 $135,100 - $165,846
13,028 Added 43.13%
43,233 $505,000
Q4 2021

Feb 02, 2022

SELL
$10.21 - $15.27 $88,653 - $132,589
-8,683 Reduced 22.33%
30,205 $339,000
Q3 2021

Nov 12, 2021

BUY
$14.07 - $17.3 $96,182 - $118,262
6,836 Added 21.33%
38,888 $568,000
Q2 2021

Aug 03, 2021

BUY
$16.62 - $18.94 $167,562 - $190,953
10,082 Added 45.89%
32,052 $556,000
Q1 2021

May 17, 2021

BUY
$15.15 - $19.78 $81,507 - $106,416
5,380 Added 32.43%
21,970 $380,000
Q4 2020

Feb 11, 2021

BUY
$16.86 - $19.67 $279,707 - $326,325
16,590 New
16,590 $306,000
Q2 2020

Aug 11, 2020

SELL
$18.24 - $21.45 $6,183 - $7,271
-339 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$16.28 - $25.63 $54,782 - $86,244
-3,365 Reduced 90.85%
339 $7,000
Q4 2019

Feb 07, 2020

SELL
$19.57 - $23.52 $1.72 Million - $2.06 Million
-87,637 Reduced 95.94%
3,704 $86,000
Q3 2019

Oct 31, 2019

SELL
$19.85 - $22.76 $75,191 - $86,214
-3,788 Reduced 3.98%
91,341 $1.83 Million
Q2 2019

Aug 09, 2019

SELL
$17.59 - $21.1 $42,427 - $50,893
-2,412 Reduced 2.47%
95,129 $2.01 Million
Q1 2019

Apr 24, 2019

SELL
$18.01 - $20.11 $36,632 - $40,903
-2,034 Reduced 2.04%
97,541 $1.96 Million
Q4 2018

Jan 30, 2019

SELL
$17.44 - $21.53 $81,741 - $100,911
-4,687 Reduced 4.5%
99,575 $1.83 Million
Q3 2018

Oct 26, 2018

BUY
$19.97 - $21.96 $22,306 - $24,529
1,117 Added 1.08%
104,262 $2.23 Million
Q2 2018

Aug 10, 2018

BUY
$20.16 - $24.68 $24,192 - $29,616
1,200 Added 1.18%
103,145 $2.22 Million
Q1 2018

May 09, 2018

BUY
$20.31 - $24.95 $147,105 - $180,712
7,243 Added 7.65%
101,945 $2.16 Million
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $1.9 Million - $2.07 Million
94,702
94,702 $2.07 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.